Filing Details
- Accession Number:
- 0001209191-16-106849
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-08 10:36:59
- Reporting Period:
- 2016-03-04
- Filing Date:
- 2016-03-08
- Accepted Time:
- 2016-03-08 10:36:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885978 | U S Physical Therapy Inc | USPH | Services-Health Services (8000) | 760364866 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1263096 | W Lawrance Mcafee | 1300 W. Sam Houston Pkwy S. Suite 300 Houston TX 77042 | Chief Financial Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-03-04 | 5,000 | $52.74 | 45,212 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.74 - $52.75, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- Includes grant of 11,360 restricted shares granted under the Company's equity plan with a four-year quarterly vesting schedule as to the lapse of restrictions thereof with 1/16 equal portions (710 shares) vesting quarterly, with the next 1/16 vesting on April 1, 2016 and thereafter equal 1/16 portions on April 1, July 1, October 1 and January 1 each year with the final 710 shares on January 1, 2020. Also Includes 27,104 restricted shares granted under the Company's equity plan. Restrictions lapse as to 3,337 shares on April 1, 2016, July 1, 2016, October 1, 2016, January 1, 2017, 2187 on April 1, 2017, July 1, 2017, October 1, 2017; 2195 on January 1, 2018 and 1250 on April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019.